Free-cash-flow proxy decreased 52.8%
Free-cash-flow proxy changed -52.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -52.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -19.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed -52.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +83.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +36.7% from the comparable as-filed period.
Operating margin changed +5197 basis points from the comparable as-filed period.
Net income changed -75.5% from the comparable as-filed period.
Gross margin changed -297 basis points from the comparable as-filed period.
Research & development changed +128.7% from the comparable as-filed period.
Shares outstanding changed -82.0% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Trade receivables changed +34.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +44.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +42.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed +30.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory / revenue changed -4029 basis points from the comparable as-filed period.
Current assets changed +25.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -2203 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -2191 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +1308 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +15.7% from the comparable as-filed period.
Receivables / revenue changed +1625 basis points from the comparable as-filed period.
Working capital / assets changed +360 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed +7.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed +78 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +7.9% from the comparable as-filed period.
Current ratio changed +16.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capex / revenue changed +12 basis points from the comparable as-filed period.
Capital expenditure changed from 0 to 8000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.